Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma
MicroRNAs (MiRNAs) carried by exosomes play pivotal roles in the crosstalk between cell components in the tumor microenvironment. Our study aimed at identifying the expression profile of exosomal miRNAs (exo-miRNAs) in the serum of multiple myeloma (MM) patients and investigating the regulation netw...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health
2023-07-01
|
| Series: | Blood Science |
| Online Access: | http://journals.lww.com/10.1097/BS9.0000000000000160 |
| _version_ | 1797732795424964608 |
|---|---|
| author | Teng Fang Hao Sun Xiyue Sun Yi He Peixia Tang Lixin Gong Zhen Yu Lanting Liu Shiyi Xie Tingyu Wang Zhenshu Xu Shuhua Yi Gang An Yan Xu Guoqing Zhu Lugui Qiu Mu Hao |
| author_facet | Teng Fang Hao Sun Xiyue Sun Yi He Peixia Tang Lixin Gong Zhen Yu Lanting Liu Shiyi Xie Tingyu Wang Zhenshu Xu Shuhua Yi Gang An Yan Xu Guoqing Zhu Lugui Qiu Mu Hao |
| author_sort | Teng Fang |
| collection | DOAJ |
| description | MicroRNAs (MiRNAs) carried by exosomes play pivotal roles in the crosstalk between cell components in the tumor microenvironment. Our study aimed at identifying the expression profile of exosomal miRNAs (exo-miRNAs) in the serum of multiple myeloma (MM) patients and investigating the regulation networks and their potential functions by integrated bioinformatics analysis. Exosomes in serum from 19 newly diagnosed MM patients and 9 healthy donors were isolated and the miRNA profile was investigated by small RNA sequencing. Differential expression of exo-miRNAs was calculated and target genes of miRNAs were predicted. CytoHubba was applied to identify the hub miRNAs and core target genes. The LASSO Cox regression model was used to develop the prognostic model, and the ESTIMATE immune score was calculated to investigate the correlation between the model and immune status in MM patients. The top six hub differentially expressed serum exo-miRNAs were identified. 513 target genes of the six hub exo-miRNAs were confirmed to be differentially expressed in MM cells in the Zhan Myeloma microarray dataset. Functional enrichment analysis indicated that these target genes were mainly involved in mRNA splicing, cellular response to stress, and deubiquitination. 13 core exo-miRNA target genes were applied to create a novel prognostic signature to provide risk stratification for MM patients, which is associated with the immune microenvironment of MM patients. Our study comprehensively investigated the exo-miRNA profiles in MM patients. A novel prognostic signature was constructed to facilitate the risk stratification of MM patients with distinct outcomes. |
| first_indexed | 2024-03-12T12:18:45Z |
| format | Article |
| id | doaj.art-72b310ea612244a4bf94cfcf1d2034de |
| institution | Directory Open Access Journal |
| issn | 2543-6368 |
| language | English |
| last_indexed | 2024-03-12T12:18:45Z |
| publishDate | 2023-07-01 |
| publisher | Wolters Kluwer Health |
| record_format | Article |
| series | Blood Science |
| spelling | doaj.art-72b310ea612244a4bf94cfcf1d2034de2023-08-30T06:12:05ZengWolters Kluwer HealthBlood Science2543-63682023-07-015319620810.1097/BS9.0000000000000160202307000-00007Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myelomaTeng Fang0Hao Sun1Xiyue Sun2Yi He3Peixia Tang4Lixin Gong5Zhen Yu6Lanting Liu7Shiyi Xie8Tingyu Wang9Zhenshu Xu10Shuhua Yi11Gang An12Yan Xu13Guoqing Zhu14Lugui Qiu15Mu Hao16a State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinac Hematology Department, Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou 350001, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinac Hematology Department, Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou 350001, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, ChinaMicroRNAs (MiRNAs) carried by exosomes play pivotal roles in the crosstalk between cell components in the tumor microenvironment. Our study aimed at identifying the expression profile of exosomal miRNAs (exo-miRNAs) in the serum of multiple myeloma (MM) patients and investigating the regulation networks and their potential functions by integrated bioinformatics analysis. Exosomes in serum from 19 newly diagnosed MM patients and 9 healthy donors were isolated and the miRNA profile was investigated by small RNA sequencing. Differential expression of exo-miRNAs was calculated and target genes of miRNAs were predicted. CytoHubba was applied to identify the hub miRNAs and core target genes. The LASSO Cox regression model was used to develop the prognostic model, and the ESTIMATE immune score was calculated to investigate the correlation between the model and immune status in MM patients. The top six hub differentially expressed serum exo-miRNAs were identified. 513 target genes of the six hub exo-miRNAs were confirmed to be differentially expressed in MM cells in the Zhan Myeloma microarray dataset. Functional enrichment analysis indicated that these target genes were mainly involved in mRNA splicing, cellular response to stress, and deubiquitination. 13 core exo-miRNA target genes were applied to create a novel prognostic signature to provide risk stratification for MM patients, which is associated with the immune microenvironment of MM patients. Our study comprehensively investigated the exo-miRNA profiles in MM patients. A novel prognostic signature was constructed to facilitate the risk stratification of MM patients with distinct outcomes.http://journals.lww.com/10.1097/BS9.0000000000000160 |
| spellingShingle | Teng Fang Hao Sun Xiyue Sun Yi He Peixia Tang Lixin Gong Zhen Yu Lanting Liu Shiyi Xie Tingyu Wang Zhenshu Xu Shuhua Yi Gang An Yan Xu Guoqing Zhu Lugui Qiu Mu Hao Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma Blood Science |
| title | Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma |
| title_full | Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma |
| title_fullStr | Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma |
| title_full_unstemmed | Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma |
| title_short | Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma |
| title_sort | exosome mirnas profiling in serum and prognostic evaluation in patients with multiple myeloma |
| url | http://journals.lww.com/10.1097/BS9.0000000000000160 |
| work_keys_str_mv | AT tengfang exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT haosun exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT xiyuesun exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT yihe exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT peixiatang exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT lixingong exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT zhenyu exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT lantingliu exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT shiyixie exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT tingyuwang exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT zhenshuxu exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT shuhuayi exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT gangan exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT yanxu exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT guoqingzhu exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT luguiqiu exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma AT muhao exosomemirnasprofilinginserumandprognosticevaluationinpatientswithmultiplemyeloma |